|
Atomistry » Magnesium » PDB 8tj0-8unh » 8un3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Magnesium » PDB 8tj0-8unh » 8un3 » |
Magnesium in PDB 8un3: Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)Enzymatic activity of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
All present enzymatic activity of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One):
3.6.5.2; Protein crystallography data
The structure of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One), PDB code: 8un3
was solved by
M.H.Ultsch,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 8un3:
The structure of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
(pdb code 8un3). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 5 binding sites of Magnesium where determined in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One), PDB code: 8un3: Jump to Magnesium binding site number: 1; 2; 3; 4; 5; Magnesium binding site 1 out of 5 in 8un3Go back to Magnesium Binding Sites List in 8un3
Magnesium binding site 1 out
of 5 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view Stereo pair view
Magnesium binding site 2 out of 5 in 8un3Go back to Magnesium Binding Sites List in 8un3
Magnesium binding site 2 out
of 5 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view Stereo pair view
Magnesium binding site 3 out of 5 in 8un3Go back to Magnesium Binding Sites List in 8un3
Magnesium binding site 3 out
of 5 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view Stereo pair view
Magnesium binding site 4 out of 5 in 8un3Go back to Magnesium Binding Sites List in 8un3
Magnesium binding site 4 out
of 5 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view Stereo pair view
Magnesium binding site 5 out of 5 in 8un3Go back to Magnesium Binding Sites List in 8un3
Magnesium binding site 5 out
of 5 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view Stereo pair view
Reference:
C.Nilewski,
M.H.Ultsch.
N/A N/A.
Page generated: Thu Dec 28 10:35:32 2023
|
Last articlesZn in 8WB0Zn in 8WAX Zn in 8WAU Zn in 8WAZ Zn in 8WAY Zn in 8WAV Zn in 8WAW Zn in 8WAT Zn in 8W7M Zn in 8WD3 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |